Search research articles
Contact Us
Filters
Showing results (1081-1090 of 1,237) with videos related to
Page
of 124
Sort By:
Blood
|
February 21, 2012
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma
Yvette L Kasamon, Heather A Jacene, Christopher D Gocke, et al.
Journal of Contemporary Brachytherapy
|
May 3, 2014
High-dose-rate intraoperative radiation therapy: the nuts and bolts of starting a program
Shalini Moningi, Elwood P Armour, Stephanie A Terezakis, et al.
Cancer Research
|
June 14, 2014
The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia?
Anne Marie Lennon, Christopher L Wolfgang, Marcia Irene Canto, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 16, 2024
Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Pancreas
Leila T Tchelebi, Diana Segovia, Koren Smith, et al.
Circulation
|
August 24, 2011
Role of RBM25/LUC7L3 in abnormal cardiac sodium channel splicing regulation in human heart failure
Ge Gao, An Xie, Shu-Ching Huang, et al.
Practical Radiation Oncology
|
March 20, 2022
Multiagent Chemotherapy and Stereotactic Body Radiation Therapy in Patients with Unresectable Pancreatic Adenocarcinoma: A Prospective Nonrandomized Controlled Trial
Colin S Hill, Lauren Rosati, Hao Wang, et al.
Blood Advances
|
March 31, 2022
The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia
Clare Sun, Yun-Ching Chen, Aina Martinez Zurita, et al.
Circulation Research
|
June 20, 2020
Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling
Jason E Fish, Carlos Perfecto Flores Suarez, Emilie Boudreau, et al.
Blood
|
November 21, 2012
Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia
Bo Yu, Yicheng Mao, Li-Yuan Bai, et al.
Cancer Research
|
October 11, 2017
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia
Nakhle S Saba, Deanna H Wong, Georges Tanios, et al.
Page
of 124
Search research articles
Search
Showing results (1081-1090 of 1,237) with videos related to
Sort By:
Page
of 124
Blood
|
February 21, 2012
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma
Yvette L Kasamon, Heather A Jacene, Christopher D Gocke, et al.
Journal of Contemporary Brachytherapy
|
May 3, 2014
High-dose-rate intraoperative radiation therapy: the nuts and bolts of starting a program
Shalini Moningi, Elwood P Armour, Stephanie A Terezakis, et al.
Cancer Research
|
June 14, 2014
The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia?
Anne Marie Lennon, Christopher L Wolfgang, Marcia Irene Canto, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 16, 2024
Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Pancreas
Leila T Tchelebi, Diana Segovia, Koren Smith, et al.
Circulation
|
August 24, 2011
Role of RBM25/LUC7L3 in abnormal cardiac sodium channel splicing regulation in human heart failure
Ge Gao, An Xie, Shu-Ching Huang, et al.
Practical Radiation Oncology
|
March 20, 2022
Multiagent Chemotherapy and Stereotactic Body Radiation Therapy in Patients with Unresectable Pancreatic Adenocarcinoma: A Prospective Nonrandomized Controlled Trial
Colin S Hill, Lauren Rosati, Hao Wang, et al.
Blood Advances
|
March 31, 2022
The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia
Clare Sun, Yun-Ching Chen, Aina Martinez Zurita, et al.
Circulation Research
|
June 20, 2020
Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling
Jason E Fish, Carlos Perfecto Flores Suarez, Emilie Boudreau, et al.
Blood
|
November 21, 2012
Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia
Bo Yu, Yicheng Mao, Li-Yuan Bai, et al.
Cancer Research
|
October 11, 2017
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia
Nakhle S Saba, Deanna H Wong, Georges Tanios, et al.
Page
of 124